FDA Inspection 1119689 — Therapak Corporation
The FDA completed an inspection of Therapak Corporation on February 5, 2020 in Claremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 5, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Claremont, CA (United States)